Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Exploration of NEUROMARK System in Participants With Chronic Migraine

NCT: NCT06862674 · COMPLETED

NCT IDNCT06862674
StatusCOMPLETED
Start Date2024-09-06
Completion2026-01-21
SponsorNeurent Medical (INDUSTRY)
First posted
Last updated

Brief Summary

Clinical exploration of NEUROMARK System in Participants with Chronic Migraine

Frequently Asked Questions

What is Clinical Exploration of NEUROMARK System in Participants With Chronic Migraine?

Clinical Exploration of NEUROMARK System in Participants With Chronic Migraine is a clinical trial registered under NCT06862674. Current status: COMPLETED.

What is the status of NCT06862674?

The current status of NCT06862674 (Clinical Exploration of NEUROMARK System in Participants With Chronic Migraine) is: COMPLETED.

When did Clinical Exploration of NEUROMARK System in Participants With Chronic Migraine start?

Clinical Exploration of NEUROMARK System in Participants With Chronic Migraine started on 2024-09-06.

Related Devices

K212666Neuromark SystemNeurent Medical K222032NEUROMARK SystemNeurent Medical K250048NEUROMARK System (NMK00301)Neurent Medical , Ltd. K261833NEUROMARK System (NMK00301)Neurent Medical , Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑